top of page
Pipeline_NP top bg.png
Pipeline
MVR-CM001

Application

Recombinant Botulinum Neurotoxin
Pipeline Overview

MVRIX is developing MVR-CM001, a recombinant botulinum toxin that can be a better alternative, using the next generation botulinum toxin production platform.

Recombinant BoNT vs. Existing BoNT
amrAsset 5_2x.png
Benefits
internet.png

​global standard for botulinum toxin production technology

antivirus.png

Safe production / preservation / distribution process

medicine.png

Possible development
of BioBetter and
new drugs

bottom of page